Impact of an hospital-based palliative care service in the community.

ISRCTN ISRCTN12144425
DOI https://doi.org/10.1186/ISRCTN12144425
Secondary identifying numbers NCP/J01
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
14/12/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Geoff Hanks
Scientific

Department of Palliative Medicine
University of Bristol
Bristol Oncology Centre
Horfield Road
Bristol
BS2 8ED
United Kingdom

Phone +44 (0)117 928 3336
Email G.W.Hanks@bris.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life
Scientific title
Study objectivesThis project aims to evaluate the cost and effectiveness of an hospital based palliative care service on subsequent care of advanced cancer patients in the community, in terms of length of index hospital admission, and need for re-admission, quality of symptom control on discharge and at home, quality of life and functional status at home, patient and carer satisfaction, impact on general practitioner/district nurse workload, and eventual place of death. The effects of such a service on the professional satisfaction of the primary care team will also be assessed. The study will be a randomised controlled trial of two levels of intervention by the palliative care team in the United Bristol Healthcare Trust. Assessments will be undertaken both during the hospital admission and after discharge over a 5 month follow-up period or to death.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSymptoms and general pathology: Pain
Intervention1. The visiting service: (the usual service delivered by the Palliative Care Team.) Initial assessment by a specialist doctor/nurse with detailed advice about problems identified in patient's case notes. Follow-up by telephone and in-person consultations with patient, family and medical and nursing staff caring for patient. Liaison also with community-based health professions and palliative care outpatient follow-up if appropriate. Advice and support provided only but over and above the normal service provided to hospital patients.
2. The telephone service: A more limited form of intervention devised as the control. No direct contact between the Palliative Care Team and the patient or family. Telephone consultation took place within one working day of referral between a senior medical PCT member and the referring doctor and also between a clinical nurse specialist and a member of the ward nursing staff involved in the patient's care. A second telephone consultation could be made if necessary but with no further follow-up or advice offered.

Patients randomised to either the visiting service or the telephone service in order to compare: pain, symptom control and global health-related 'quality of life'; satisfaction of patients, carers and health professionals; and use of health service resources.
Intervention typeOther
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2001
Completion date31/12/2001

Eligibility

Participant type(s)Patient
Age groupNot Specified
Lower age limit18 Years
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteria1. Patients 18 and over newly referred to PCT
2. Able to understand instructions and provide written consent within one day of referral
3. Physically and emotionally well enough to consider participating in a study and to reflect on their illness experience with a researcher
4. Not likely to be discharged with 24 hours of referral. PCT advice requested urgently
5. No strong preference expressed by the patient or patient's clinician for the visiting service of the PCT only
6. Aware of diagnosis
7. Willing to answer questions and be followed up for 4 weeks
Key exclusion criteriaWritten consent not provided within one day of referral.
Date of first enrolment01/01/2001
Date of final enrolment31/12/2001

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Department of Palliative Medicine
Bristol
BS2 8ED
United Kingdom

Sponsor information

Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Government

NHS Cancer National Research and Development Programme (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 23/09/2002 Yes No